In contrast to the LLC 46 NRAS KO model, orthotopic lung tumors established with the mKRC.1 cell line exhibited a significant single-agent anti-tumor response to MRTX-849 (Figure 4A and representative μCT images in Suppl. This evidence concerns the gene NRAS and neoplasm.